scholarly journals Concise Review: Stem Cell Microenvironment on a Chip: Current Technologies for Tissue Engineering and Stem Cell Biology

2015 ◽  
Vol 4 (11) ◽  
pp. 1352-1368 ◽  
Author(s):  
DoYeun Park ◽  
Jaeho Lim ◽  
Joong Yull Park ◽  
Sang-Hoon Lee
Symmetry ◽  
2015 ◽  
Vol 7 (4) ◽  
pp. 2025-2037 ◽  
Author(s):  
Florian Murke ◽  
Symone Castro ◽  
Bernd Giebel ◽  
André Görgens

Stem Cells ◽  
2012 ◽  
Vol 30 (3) ◽  
pp. 386-391 ◽  
Author(s):  
Kristina I. Boström ◽  
Alan Garfinkel ◽  
Yucheng Yao ◽  
Medet Jumabay

2018 ◽  
pp. 1402-1423
Author(s):  
Martin Reinhardt ◽  
Shibashish Giri ◽  
Augustinus Bader

Currently, practical application of nanotechnological approaches and stem cell therapies remains a challenge in both preclinical and clinical settings. Many existing problems in tissue engineering to organ engineering have been solved by the combined approaches of nanotechnology and stem cell biology, but significant barriers remain. Details about the role of various types of nanomaterial in preclinical and clinical research have been reviewed elsewhere, but scant information exists about the influence of nanomaterials on stem cell biology. Herein, the authors highlight the current advances of nanotechnological approaches for expansion, differentiations, harvesting, labeling, imagining, tissue engineering, and organ engineering of different types of stem cells. The preclinical outcome of in vitro and in vivo animal experimentations along with some examples of clinical outcomes of nanomaterials on stem cell research is the main focus of this chapter. This book chapter might be an impetus for the present generation of young scientists to revolutionize the coming generation of effective human healthcare.


2014 ◽  
Vol 38 (9) ◽  
pp. 1819-1824 ◽  
Author(s):  
Marco Mravic ◽  
Greg Asatrian ◽  
Chia Soo ◽  
Claire Lugassy ◽  
Raymond L. Barnhill ◽  
...  

2014 ◽  
Vol 6 (245) ◽  
pp. 245sr2-245sr2 ◽  
Author(s):  
Sangeeta N. Bhatia ◽  
Gregory H. Underhill ◽  
Kenneth S. Zaret ◽  
Ira J. Fox

Despite the tremendous hurdles presented by the complexity of the liver’s structure and function, advances in liver physiology, stem cell biology and reprogramming, and the engineering of tissues and devices are accelerating the development of cell-based therapies for treating liver disease and liver failure. This State of the Art Review discusses both the near- and long-term prospects for such cell-based therapies and the unique challenges for clinical translation.


Author(s):  
Ajaykumar Vishwakarma ◽  
Paul Sharpe ◽  
Songtao Shi ◽  
Murugan Ramalingam

Sign in / Sign up

Export Citation Format

Share Document